In the published Phase 2 research (Jastreboff et al., NEJM 2023), Retatrutide produced the largest body-weight outcomes of any single-compound incretin programme reported to date, distinguishing the triple-agonist class from dual agonists like Tirzepatide and single-target agonists like Semaglutide
Reddys, and Cipla are progressing toward biosimilar filings, focusing on price-sensitive markets where reimbursement limits access to branded semaglutide
Seek medical advice if fatigue is severe, worsening, or accompanied by chest pain, breathlessness, dehydration, persistent vomiting, or signs of hypoglycaemia in people with diabetes
Two cohort studies further supported these findings, showing GLP-1 use correlated with reduced prosthetic joint infections, fewer 90-day readmission rates, and reduced 2-year revisions in total knee and hip arthroplasty patients
Alternative Management Plans If you were taking Ozempic for type 2 diabetes, youll need an alternative glucose management plan immediately